MedTrace Logo

The Provider Insurance Revenue Study in Healthcare Providers in the United States of America

NCT04587245 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-10-18

No results posted yet for this study

Summary

The investigators are enrolling 100 healthcare Provider volunteers (n=100) from across the United States to help to evaluate and document the financial impact of COVID-19 on Physicians and other healthcare Providers. This investigation will compare individual Physician revenues before and after the advent of the COVID-19 pandemic. The investigators expect to be able to differentiate between revenues lost due to the COVID-19-driven business recession and revenues lost due to the manipulation of reimbursement processes by insurance companies. The inextricable linkage between Payer and Physician revenues suggests that Payer revenues are higher at the direct expense of Physicians, since both streams come from the same sources of funding. The secondary objective is aimed at revealing the methods Payers use to retain more money.

Conditions

  • Covid19
  • Financial Disclosure

Interventions

OTHER

Online questionnaire and interviews

Online questionnaire, financial statements (one month per quarter in 2020) submitted electronically, interview with professional accounting firm and review of data and exit Interview

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • ND Sciences, LLC

    lead INDUSTRY

Principal Investigators

  • Henry Broeska, PhD · University of California Irvine Beall Applied Innovation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-10-15
Completion
2022-10-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04587245 on ClinicalTrials.gov